A defining molecular signature of FXTAS is the elevation of premutation FMR1 mRNA levels with no detectable or only a modest reduction in FMRP protein levels (Tassone et al., 2000; Kenneson et al., 2001; Pretto et al., 2014). This evidence concerns the gene FMR1 and fragile X-associated tremor/ataxia syndrome.